Category: Federal Forum Posters
Purpose: The respiratory multiplex panel is a polymerase chain reaction test using a nasopharyngeal swab. It can detect 20 of the most common respiratory pathogens in about an hour with high sensitivity and specificity. Previous evaluations have shown using this type of diagnostic tool can reduce antibiotic treatment duration, days in ICU, and overall healthcare costs. The objective of this quality improvement project is to evaluate whether respiratory multiplex panel results lead to changes in inpatient antimicrobial treatment.
Methods: Patients with respiratory multiplex results from February 2018 to June 2018 will be identified through laboratory results. Patients not admitted to the hospital or that have coinfections will be excluded. A retrospective chart review will be conducted to collect the following data from the electronic health record: patient age, patient gender, presence of beta-lactam allergy, time from respiratory symptom complaint to multiplex collected, antibiotic use prior to multiplex results, multiplex panel results in categories and species, and antibiotic use after multiplex results obtained. Other data points that will be collected are duration of antibiotic therapy, sputum culture results with correlation to multiplex results, and hospital length of stay. The duration of antibiotic treatment will be compared between the group that has a positive viral multiplex and the group that has a negative multiplex.
Results: Not Applicable
Conclusion: Not Applicable
Christopher Espinosa– PGY1 Pharmacy Resident, Orlando VA Medical Center, St. Cloud, FL